scholarly journals 2-Hydroxy-3-methoxybenzoic acid attenuates mast cell-mediated allergic reaction in mice via modulation of the FcεRI signaling pathway

2016 ◽  
Vol 38 (1) ◽  
pp. 90-99 ◽  
Author(s):  
Yeon-Yong Kim ◽  
In-Gyu Je ◽  
Min Jong Kim ◽  
Byeong-Cheol Kang ◽  
Young-Ae Choi ◽  
...  
2019 ◽  
Vol 8 (3) ◽  
pp. 353-360 ◽  
Author(s):  
Qin Li ◽  
Lingxi Zhang ◽  
Lili Gu ◽  
Bo Zhang ◽  
Jiaqi Lu ◽  
...  

Qingkailing injection (QKLI) is a kind of multi-component traditional Chinese medicine injection.


2011 ◽  
Vol 32 (1) ◽  
pp. 43-48 ◽  
Author(s):  
Monika Jedrzejczak-Czechowicz ◽  
Anna Lewandowska-Polak ◽  
Marzanna Jarzebska ◽  
Marek L. Kowalski

2018 ◽  
Vol 19 (12) ◽  
pp. 4092 ◽  
Author(s):  
Chen Shao ◽  
Bingjie Fu ◽  
Ning Ji ◽  
Shunli Pan ◽  
Xiaoxia Zhao ◽  
...  

Alisol B 23-acetate (AB23A), a natural triterpenoid, has been reported to exert hepatoprotective and antitumor activities. Aiming to investigate the anti-inflammatory activity, this study examined the effect of AB23A on mast cells and allergic reaction. AB23A inhibited the degranulation of mast cells stimulated by immunoglobulin E/antigen (IgE/Ag), and also decreased the synthesis of leukotriene C4 (LTC4), production of interlukin-6 (IL-6), and expression of cyclooxygenase-2 (COX-2) in a concentration-dependent manner with no significant cytotoxicity in bone marrow-derived mast cells (BMMCs). AB23A inhibited spleen tyrosine kinase (Syk) and the downstream signaling molecules including phospholipase Cγ (PLCγ), serine-threonine protein kinase/inhibitor of nuclear factor kappa-B kinase/nuclear factor kappa-B (Akt/IKK/NF-κB), and mitogen-activated protein kinases/cytosolic phospholipase A2 (MAPK/cPLA2). Furthermore, AB23A blocked mobilization of Ca2+. Similar results were obtained in other mast cell lines Rat basophilic leukemia (RBL)-2H3 cells and a human mast cell line (HMC-1). In addition, AB23A attenuated allergic responses in an acute allergy animal model, passive cutaneous anaphylaxis (PCA). Taken together, this study suggests that AB23A inhibits the activation of mast cells and ameliorates allergic reaction, and may become a lead compound for the treatment of mast cell-mediated allergic diseases.


2019 ◽  
Vol 34 (2) ◽  
pp. 401-408
Author(s):  
Jianli Wang ◽  
Yongjing Zhang ◽  
Jue Wang ◽  
Rui Liu ◽  
Guiping Zhang ◽  
...  

2004 ◽  
Vol 26 (3) ◽  
pp. 445-454 ◽  
Author(s):  
Ho‐Jeong Na ◽  
Hyun‐Ja Jeong ◽  
Seung‐Heon Hong ◽  
Chung‐Yeon Hwang ◽  
Wung‐Suk Cha ◽  
...  
Keyword(s):  

2012 ◽  
Vol 143 (1) ◽  
pp. 151-157 ◽  
Author(s):  
Yue Lu ◽  
Ying Li ◽  
Meihua Jin ◽  
Ju Hye Yang ◽  
Xian Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document